Lithium Citrate Syrup and Recombinate recombinant
Determining the interaction of Lithium Citrate Syrup and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Citrate Syrup-Recombivax
- Lithium Citrate Syrup-Recombivax HB
- Lithium Citrate Syrup-Recombivax HB Adult
- Lithium Citrate Syrup-Recombivax HB Dialysis Formulation
- Lithium Citrate Syrup-Recombivax HB Pediatric/Adolescent
- Lithium Citrate Syrup-Recort Plus
- Recombinate recombinant-Lithium Controlled-Release and Extended-Release Tablets
- Recombinate recombinant-Lithium ER
- Recombinate recombinant-Lithium Oral Solution
- Recombinate recombinant-Lithium Salts
- Recombinate recombinant-Lithium Syrup and Oral Solution
- Recombinate recombinant-Lithobid